ROADSHOWS began this week for the $2bn equity fundraising of Ares-Serono, which will list the world's third largest biotech company in New York. Merrill Lynch is global co-ordinator of the deal, which will be priced on July 26. A total of 973,336 new shares and 973,336 old shares will be sold by the Bertarelli family. The family will reduce its stake from 70% to just over 50%.. There is a greenshoe of 194,668 existing shares. Current shareholders will get the right to buy one new share for every 14 shares held under a rights offering.
July 14, 2000